Home
>
National Drug Code (NDC)
>
Triple Antibiotic HC
Triple Antibiotic HC - 57319-344-25 - (Neomycin sulfate and Polymyxin B Sulfate, Bacitracin Zinc and Hydrocortisone)
Drug Information of Triple Antibiotic HC
| Product NDC: | 57319-344 |
| Proprietary Name: | Triple Antibiotic HC |
| Non Proprietary Name: | Neomycin sulfate and Polymyxin B Sulfate, Bacitracin Zinc and Hydrocortisone |
| Active Ingredient(s): | 400; 10; 3.5; 10000 [USP'U]/g; mg/g; mg/g; [USP'U]/g & nbsp; Neomycin sulfate and Polymyxin B Sulfate, Bacitracin Zinc and Hydrocortisone |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Triple Antibiotic HC
| Product NDC: | 57319-344 |
| Labeler Name: | Phoenix Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA064068 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19951030 |
Package Information of Triple Antibiotic HC
| Package NDC: | 57319-344-25 |
| Package Description: | 1 TUBE in 1 CARTON (57319-344-25) > 3.5 g in 1 TUBE |
NDC Information of Triple Antibiotic HC
| NDC Code | 57319-344-25 |
| Proprietary Name | Triple Antibiotic HC |
| Package Description | 1 TUBE in 1 CARTON (57319-344-25) > 3.5 g in 1 TUBE |
| Product NDC | 57319-344 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Neomycin sulfate and Polymyxin B Sulfate, Bacitracin Zinc and Hydrocortisone |
| Dosage Form Name | OINTMENT |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19951030 |
| Marketing Category Name | ANDA |
| Labeler Name | Phoenix Pharmaceutical, Inc. |
| Substance Name | BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Strength Number | 400; 10; 3.5; 10000 |
| Strength Unit | [USP'U]/g; mg/g; mg/g; [USP'U]/g |
| Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Decreased Cell Wall Synthesis & Repair [PE],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
